NeuroOne Medical Technologies Corporation (NMTC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NMTC Revenue Growth
NMTC Revenue Analysis (2014–2025)
As of May 8, 2026, NeuroOne Medical Technologies Corporation (NMTC) generated trailing twelve-month (TTM) revenue of $8.7 million, reflecting significant decline in growth of -11.7% year-over-year. The most recent quarter (Q1 2026) recorded $2.9 million in revenue, up 5.5% sequentially.
Looking at the longer-term picture, NMTC's 5-year compound annual growth rate (CAGR) stands at +44.4%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $12.1 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including LIVN (+12.4% YoY), NVCR (+8.5% YoY), and MDT (+6.9% YoY), NMTC has underperformed the peer group in terms of revenue growth. Compare NMTC vs LIVN →
NMTC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NMTCCurrent | $9M | -11.7% | +44.4% | -34.9% | |
 LIVN | $1.4B | +12.4% | +8.2% | 14.4% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% |
NMTC Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $12.1M | +250.4% | $8.1M | 67.3% | $-4,226,473 | -34.9% |
| 2024 | $3.5M | +76.9% | $1.1M | 31.3% | $-11,887,209 | -344.3% |
| 2023 | $2.0M | +1040.7% | $457K | 23.4% | $-11,955,250 | -612.3% |
| 2022 | $171K | -3.9% | $-70,794 | -41.4% | $-10,030,765 | -5860.2% |
| 2021 | $178K | -90.8% | $-97,749 | -54.9% | $-10,218,211 | -5735.9% |
| 2020 | $1.9M | - | $1.9M | 96.3% | $-4,902,261 | -254.5% |
| 2019 | $0 | - | $-27,569 | - | $-5,813,394 | - |
| 2018 | $0 | - | $-21,667 | - | $-3,210,700 | - |
| 2017 | $0 | - | $-17,633 | - | $-3,072,321 | - |
| 2016 | $0 | -100.0% | $-7,740 | - | $-32,611 | - |
See NMTC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NMTC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NMTC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNMTC — Frequently Asked Questions
Quick answers to the most common questions about buying NMTC stock.
Is NMTC's revenue growth accelerating or slowing?
NMTC revenue declined -11.7% year-over-year, contrasting with the 5-year CAGR of +44.4%. TTM revenue fell to $9M. This reverses the prior growth trend.
What is NMTC's long-term revenue growth rate?
NeuroOne Medical Technologies Corporation's 5-year revenue CAGR of +44.4% reflects the variable expansion pattern. Current YoY growth of -11.7% is below this long-term average.
How is NMTC's revenue distributed by segment?
NMTC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.